ANTIBODIES BINDING TO PLASMODIUM CIRCUMSPOROZOITE PROTEIN AND USES THEREOF

Recombinant fusion proteins targeting CD47 and PD-L1, preparation and use thereof

PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF

USE OF CD44 ANTIBODY IN PREPARATION OF MEDICINE FOR TREATING PARKINSON'S DISEASE

Combination taxoid nanoemulsion with immunotherapy in cancer

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs

TETRAVALENT SYMMETRIC BISPECIFIC ANTIBODIES

SEMG2 ANTIBODY AND USE THEREOF

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

ANTIGEN-BINDING MOLECULES AGAINST ALPPL2 AND/OR ALPP AND USES THEREOF

Anti-O2 antibodies and uses thereof

ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF

Compositions and methods for treating age-related diabetes and related disorders

Antibodies to TGF-Beta

HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR

METHODS FOR DNA-DEPENDENT TARGETING OF A CELL PERMEANT ANTIBODY

Heterodimeric Bispecific Antibodies

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF MUCOSAL VACCINES

FUSION ANTIBODY FOR PRESENTING ANTIGEN-DERIVED T CELL ANTIGEN EPITOPE OR PEPTIDE CONTAINING SAME ON CELL SURFACE, AND COMPOSITION COMPRISING SAME

Tetravalent bispecific antibody against PD-1 and PD-L1

USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS

METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST

VECTORIZED ANTIBODIES (vAb) AND USES THEREOF

AGONIST ANTIBODIES AGAINST ENDOGLIN AND USES THEREOF

TREATMENT WITH A BISPECIFIC ANTIBODY THAT BINDS CTLA4 AND PD1

ANTI-LAG3 MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

MMP-9 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE THEREOF

Anti-FcRn Antibodies

PDE5 compositions and methods for immunotherapy

ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF

HOMODIMER-TYPE BISPECIFIC ANTIBODY AGAINST HER2 AND CD3 AND USE THEREOF

ANTI-CD 160 BINDING MOLECULES FOR TREATING DISEASES

HUMAN HENDRA VIRUS AND NIPAH VIRUS ANTIBODIES AND METHODS OF USE THEREFOR

HUMANIZED MONOCLONAL ANTIBODY FOR 2019 NOVEL CORONAVIRUS AND USE THEREOF

Human monoclonal antibodies against yellow fever virus and uses therefor

BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE

Immunoconjugates

ANTI-CD3 and ANTI-CD123 Bispecific Antibody and Use Thereof

LILRB3 ANTIBODY MOLECULES AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Anti-VTCN1 antibodies and antibody drug conjugates

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer

ANTI-CD137 CONSTRUCTS, MULTISPECIFIC ANTIBODY AND USES THEREOF

ANTIBODY MOLECULES WHICH BIND CD22

METHOD FOR PREDICTING PATIENT RESPONSE TO IMMUNOTHERAPY

ANTIBODIES AGAINST N-ACETYLGLUCOSAMINE AND N-ACETYL-GALACTOSAMINE

HUMAN ANTIBODIES TO ALPHAVIRUSES

Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumors

USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENESS OF MUC 16-POSITIVE CANCER TREATMENT

ANTI-ASGR1 ANTIBODY CONJUGATES AND USES THEREOF

TREATMENT OF CK8 POSITIVE CANCERS IN RELATION WITH K-RAS GENE STATUS

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

ANTI-OX40 ANTIBODY AND USE THEREOF

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY

PERTUSSIS TOXIN BINDING PROTEIN

Anti-CD30L antibodies and uses thereof

SERUM ALBUMIN BINDERS

ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME, AND METHODS OF USING THE SAME

Neutralizing antibodies to GP120 and their use

MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-PSMA ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF

Antibodies specific for FLT3 and their uses

METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING RHEUMATOID ARTHRITIS

BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS

HETERODIMERIC PROTEINS

CHEMOPREVENTION USING CONTROLLED- RELEASE FORMULATIONS OF ANTI-INTERLEUKIN 6 AGENTS, SYNTHETIC VITAMIN A ANALOGUES OR METABOLITES, AND ESTRADIOL METABOLITES

Procoagulant Antibodies

MONOCLONAL ANTIBODY AGAINST STIM1

MULTIMERIC CORONAVIRUS BINDING MOLECULES AND USES THEREOF

CLAUDIN-6 BINDING MOLECULES AND USES THEREOF

ANTI-PVRIG AND ANTI-TIGIT ANTIBODIES FOR ENHANCED NK-CELL BASED TUMOR KILLING

ANTI-IL-1-BETA ANTIBODIES

METHODS OF TREATMENT WITH ANTIBODIES AGAINST BCMA AND CD3

Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF Fab

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTION

Epstein-Barr virus antibodies and uses thereof

USES OF ANTI-TGF-BETA ANTIBODIES AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R)

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC ANTIBODIES USING PLATELET-DERIVED MICROPARTICLES

Multi-specific antigen binding molecules targeting HIV and methods of use

Therapy for the Treatment of Cancer

AGENT FOR PREVENTION OR TREATMENT OF DIABETIC AUTONOMIC NEUROPATHY

NOVEL ANTI-FGFR2B ANTIBODIES

MONOCLONAL ANTIBODY AGAINST STIM1

ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF

NEUTRALIZING MONO-SPECIFIC IgY ANTIBODIES TO INHIBIT OR TREAT SARS-COV-2 CORONAVIRUS INFECTION

ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

Anti-CD47 antibody and uses thereof

Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer

DC-SIGN ANTIBODY DRUG CONJUGATES

TREATMENT OF ADRENOCORTICAL CARCINOMA WITH SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS (SGRMS) AND ANTIBODY CHECKPOINT INHIBITORS

GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

FGFR2 INHIBITORS ALONE OR IN COMBINATION WITH IMMUNE STIMULATING AGENTS IN CANCER TREATMENT

TREATING IMMUNE PLATELET DISORDERS USING ANTIGEN-BINDING FRAGMENTS

Chimeric antigen receptor and methods of use thereof

Anti-transferrin receptor antibody and uses thereof

ANTIBODIES AGAINST CD73 AND USES THEREOF

ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF

IMPROVED SERUM ALBUMIN BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES

Chimeric antigen receptors targeting B-cell maturation antigen

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASE

TGF-BETA INHIBITORS AND USE THEREOF

Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof

CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Claudin-6 antibodies and drug conjugates

MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE

Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods of use

ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF A FIBROTIC CONDITION

ENGINEERED IMMUNE CELLS

Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer

Modified Antibody

Anti-CCR8 antibodies

CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF

Antibodies against MFAP4

Pertuzumab variants and evaluation thereof

Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

ANTI-TNFR2 ANTIBODY AND USES THEREOF

PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS

Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy

ANTI IL-36R ANTIBODIES COMBINATION THERAPY

Compounds for treatment of eye diseases

Anti-transferrin receptor (TFR) antibody and uses thereof

Monoclonal antibodies and cocktails for treatment of Ebola infections

METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS

ANTI-TAU ANTIBODIES AND METHODS OF USE

ANTI-C5 ANTIBODY FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER

LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODY

Manufacturing Methods for Producing Anti-TNF Antibody Compositions

MONOCLONAL ANTIBODIES THAT TARGET HUMAN CD47 PROTEIN

ANTI-IL-27 ANTIBODIES AND USES THEREOF

HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)

ANTIBODIES AGAINST LIF AND USES THEREOF

Bispecific antibody constructs for CDH3 and CD3

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOF

Manufacturing Methods for Producing Anti-TNF Antibody Compositions

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION

MULTISPECIFIC NANOBODIES CHIMERIC ANTIGEN RECEPTOR AND T-CELL ENGAGER, NUCLEIC ACID, EXPRESSING CELL THEREOF, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELL

ANTI-TIGIT ANTIBODIES, MULTISPECIFIC ANTIBODIES COMPRISING THE SAME, AND METHODS OF USING THE SAME

ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Anti-CD38 antibodies

POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER

ANTI-GDF15 ANTIBODY

TREATMENT OF CANCER COMPRISING ADMINISTRATION OF Vg9Vd2 T CELL RECEPTOR BINDING ANTIBODIES

AGENT FOR USE IN THE TREATMENT AND PROPHYLAXIS OF POSTISCHEMIC TISSUE INJURY

METHODS FOR CANCER IMMUNOTHERAPY

Antigen binding molecules that bind LIGHT

ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE

METHODS OF USE OF ANTI-CD33 ANTIBODIES

ANTI-PDL1 ANTIBODIES AND USES THEREOF

METHODS OF TREATING FIBROBLAST GROWTH FACTOR 19-MEDIATED CANCERS AND TUMORS

METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS, AND IMMUNOTOXINS

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

CD19 BINDING AGENTS AND USES THEREOF

Heterodimeric Fc-fused proteins

ANTI-FACTOR D ANTIBODIES AND USES THEREOF

METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY

ANTI-SERUM ALBUMIN ANTIBODIES

Compositions and methods for delivery of nucleic acids to cells

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING A SAGE1-RELATED CONDITION

COMPOSITIONS AND METHODS FOR THE CYTOPLASMIC DELIVERY OF ANTIBODIES AND OTHER PROTEINS

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTIGEN LOADING

NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA

Chimeric antigen receptors targeting B-cell maturation antigen

METHOD FOR TREATING CANCER BY ADMINISTRATION OF ANTIBODIES THAT BIND TO EXTRACELLULAR REGION PORTION OF MCEMP1 PROTEIN

TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES

ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF

A T cell-based immunotherapy for central nervous system viral infections and tumors

NUCLEIC ACID ENCODING LILRB1-BASED CHIMERIC ANTIGEN RECEPTOR

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

THERAPEUTIC COMPOSITIONS COMPRISING AN AMYLOID BETA ANTIBODY OR VACCINE FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION

Checkpoint blockade and microsatellite instability

Combinations of mRNAs encoding immune modulating polypeptides and uses thereof

METHODS FOR TREATING CANCER

Anti-Alpha-Synuclein Monoclonal Antibodies, and Methods Using Same

NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTICANCER COMBINATION THERAPY

Oral Delivery Compositions for Obesity Management

METHODS OF USE OF ANTI-TREM2 ANTIBODIES

METHODS FOR TREATING CANCER COMPRISING LOW DOSE RADIATION

CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN REGIMENS

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

ENGINEERED ANTIBODIES AND METHODS OF TREATMENT

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER

Compositions and Methods for Targeting Cancer Stem Cells

HUMANIZED ANTI-GLYCOPROTEIN IB ALPHA (GPIBALPHA) ANTIBODIES

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof

COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA

ANTI-INTERLEUKIN 1 BETA ANTIBODIES FOR TREATMENT OF SICKLE CELL DISEASE

METHODS FOR TREATING OR PREVENTING MIGRAINE HEADACHE

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

INFECTIOUS DISEASE VACCINES

Heterodimeric proteins for modulating gamma delta T cells

ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF

METHODS FOR TREATMENT OF MOTOR NEURON DISEASES

Treatment for primary amyloidosis with anti-BCMA binding protein

PSGL-1 MODULATORS AND USES THEREOF

ANTI-ADGRE2 ANTIBODIES AND USES THEREOF

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody

Bispecific GD2 and B7H3 Binding Molecules and Methods of Use

Anti-PD-1 antibodies and uses thereof

STABLE HIGH-CONCENTRATION FORUMULATION OF NIMOTUZUMAB ANTIBODY

C-terminal anti-sclerostin antibody variants

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

TREATMENT OF NEUROINFLAMMATORY DISEASE

Anti-TIGIT and anti-CD96 antibodies

CHIMERIC ANTIGEN RECEPTOR

Toxicity Management for Anti-Tumor Activity of CARs

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

B7-H4 ANTIBODIES AND METHODS OF USE THEREOF

BIFUNCTIONAL FUSION PROTEIN AND PHARMACEUTICAL USE THEREOF

CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME

METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH PI3 KINASE DELTA INHIBITORS

Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine

Therapies for B cell malignancies

PROTEIN FORMULATIONS AND METHODS OF MAKING SAME

MRNA-ENCODED ANTIBODIES FOR CONTRACEPTION

Chimeric antigen receptors targeting B-cell maturation antigen

METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES

ANTI-CD3 ANTIBODIES AND METHODS OF USE

TREATMENT OF THERAPY-RESISTANT HER-2 POSITIVE BREAST CANCER

Receptors providing targeted costimulation for adoptive cell therapy

METHODS OF CANCER TREATMENT WITH ANTI-OX40 ANTIBODY IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS

Antibodies specific for CD70 and their uses

Compositions and methods for treatment of thyroid eye disease

PD-L1 TARGETED CHIMERIC PROTEINS AND USES THEREOF

ANTI-HUMAN PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) ANTIBODY AND USE THEREOF

DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY

ANTIBODIES TO CD3 AND BCMA, AND BISPECIFIC BINDING PROTEINS MADE THEREFROM

GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHOD OF MAKING AND USING THEREOF

ANTI-TM4SF4 ANTIBODY AND USES THEREOF

Anti-CSP antibodies

HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS

Methods and compositions relating to covid antibody epitopes

INSERTABLE VARIABLE FRAGMENTS OF ANTIBODIES AND MODIFIED A1-A2 DOMAINS OF NKG2D LIGANDS

RADIOHALOGEN PROSTHETIC MOIETIES AND RADIOLABELED BIOMOLECULES

METHOD OF TREATING CANCER BY ADMINISTRATION OF AN ANTI-PD-1 OR ANTI-PD-L1 THERAPEUTIC AGENT VIA A LYMPHATIC DEVLIERY DEVICE

Glycan-Interacting Compounds and Methods of Use

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

METHODS FOR TREATING PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy

COMPOSITIONS AND METHODS FOR DETECTING CELLS UNDERGOING FERROPTOSIS USING AN ANTIBODY

COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS

Antibodies binding to HLA-A2/WT1

SEPARATED ANTIGEN AXL BINDING PROTEIN AND USE THEREOF

COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR 1 TARGETING

Antibodies that bind to OX40 and their uses

BCMA AS A TARGET FOR T CELL REDIRECTING ANTIBODIES IN B CELL LYMPHOMAS

COMBINATION IMMUNOTHERAPY OF IL-15 AND CD40 AGONIST IN CANCER TREATMENT

MOLECULE CAPABLE OF BINDING TO HUMAN 4-1BB AND ITS APPLICATION THEREOF

IL-1 Receptor Accessory Protein Inhibitors and Uses Thereof

Anti-TrkB monoclonal antibodies and methods of use

ANTI-GAL3 ANTIBODIES AND METHODS OF USE FOR INSULIN RESISTANCE

ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

Bispecific PD-1 and TIGIT binding proteins and uses thereof

CTLA4 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE THEREOF

PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES

PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF

ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF

MODULATION OF STIMULATORY AND NON-STIMULATORY MYELOID CELLS

Connexin 43 antibodies and use thereof

HUMANIZED ANTI-CLAUDIN-1 ANTIBODIES AND USES THEREOF

ANTIBODIES BINDING TO GPRC5D

MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

Humanized Antibodies That Recognize Alpha-Synuclein

Anti-ApoE antibodies

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

EXTRACELLULAR VESICLES AND USES THEREOF FOR ANTIBODY DELIVERY

METHODS AND COMPOSITIONS FOR USE AS A PRE-TREATMENT FOR HIV THERAPIES

ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE MARKERS ON LEUCOCYTES, AND USING THESE TO GUIDE ANTI-CLEVER-1 BASED CANCER TREATMENT

ANTI-DLL4/VEGF DUAL VARIABLE DOMAIN IMMMUNOGLOBULIN AND USES THEREOF

Heterodimeric antibodies that bind CD3 and CD38

BINDING MOLECULES TO ARGINASE II [ARG2]

ANTIBODY SPECIFICALLY RECOGNIZING ITIH1, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR IMPROVING INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers